bpc-157 tendon healing study 10 Incredible Benefits exclusion Have we been lied Weight:5mg

bpc-157 tendon healing study 10 Incredible Benefits exclusion Have we been lied Weight:5mg

Have we been lied to about peptides? | Steven Bartlett | Facebook

Key Safety Differentiators → No IGF-1 elevation: AOD-9604 does not stimulate IGF-1, meaning it avoids risks such as organ/tissue overgrowth or acromegaly → No glucose disruption: Clinical data shows it does not impair insulin sensitivity or worsen blood sugar regulation → Comparable to placebo: In obesity trials, the incidence of adverse effects was similar to placebo groups, underscoring its tolerability Legal Status of AOD-9604 → United States: AOD-9604 is not FDA-approved as a drug, dietary supplement, or weight loss therapy

exclusion

Weight:5mg

But from a biological standpoint, comparing semaglutide to BPC-157 is like comparing insulin to ibuprofen